Efficacy of abatacept or infliximab in RA patients with an inadequate response to MTX: Results from a 1-year double-blind randomized clinical trial

Category Primary study
JournalScandinavian Journal of Rheumatology
Year 2008
This article has no abstract
Epistemonikos ID: 65912dd0eee46eb60b272ebf27e3ec5e66906928
First added on: Oct 21, 2017